MedPath

Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen

Phase 4
Completed
Conditions
Fever
Pain
Interventions
Registration Number
NCT01334944
Lead Sponsor
Cumberland Pharmaceuticals
Brief Summary

The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the hospital setting.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Pain: Patients with baseline Visual Analog Scale assessment >3, -and/or- Fever: Patients with temperature >101°F.
Exclusion Criteria
  1. Patients with inadequate IV access
  2. Patients <18 years of age
  3. History or allergy or hypersensitivity to any component of intravenous ibuprofen, aspirin (or aspirin related products) or non-steroidal anti-inflammatory drug (NSAIDs)
  4. Active hemorrhage or clinically significant bleeding
  5. Pregnant or nursing
  6. Patients in the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery
  7. Inability to understand the requirements of the study, be willing to provide written informed consent (as evidenced by signature on an informed consent document approved by an Institutional Review Board [IRB]), and agree to abide by the study restrictions
  8. Refusal to provide written authorization for use and disclosure of protected health information

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Intravenous ibuprofenIntravenous ibuprofenIntravenous ibuprofen (400 mg or 800 mg intravenous ibuprofen administered intravenously over 5-10 minutes) will be administered as a single dose during the 5-10 minute Treatment Period.
Primary Outcome Measures
NameTimeMethod
To Determine the Safety of a Single Dose of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Treatment of Fever or Pain in the Hospital Setting.1 hour

The change from baseline to one hour post administration of intravenous ibuprofen in vital sign assessments (Diastolic Blood Pressure).

To Determine the Safety of a Single Dose of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Treatment of Fever or Pain in the Hospital Setting1 hour

The change from baseline to one hour post administration of intravenous ibuprofen in vitals sign assessments (Temperature)

Secondary Outcome Measures
NameTimeMethod
To Determine the Efficacy of a Single Dose of 400 mg Intravenous Ibuprofen Administered Over 5-10 Minutes for the Treatment of Fever4 hours

The change in temperature from baseline over the 4 hours following intravenous ibuprofen administration

To Determine the Efficacy of a Single Dose of 800 mg Intravenous Ibuprofen Administered Over 5-10 Minutes for the Treatment of Pain (Mild to Moderate or Moderate to Severe).4 hours

The change in patient self-assessment of pain utilizing the visual analog scale (VAS) from baseline over the 4 hours following intravenous ibuprofen administration. The VAS is a continuous scale compromised of a horizontal line, one hundred millimeters in length, anchored by 2 verbal descriptors (No Pain, Worst Possible Pain). The VAS is self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity. Using a ruler, the score is determined by measuring the distance, in mm, on the 100 mm line between the "No Pain" anchor and the subject's mark. The score would be between o and 100.

To Determine the Safety of a Multiple Doses of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Treatment of Fever or Pain24 hours

The incidence of treatment-emergent adverse events occurring through extended dosing.

Trial Locations

Locations (13)

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

UCSD

🇺🇸

San Diego, California, United States

The Moses H. Cone Memorial Hospital

🇺🇸

Greensboro, North Carolina, United States

Grady

🇺🇸

Atlanta, Georgia, United States

University of Miami - Miller School of Medicine

🇺🇸

Miami, Florida, United States

Columbia

🇺🇸

New York, New York, United States

Lankenau

🇺🇸

Wynnewood, Pennsylvania, United States

Beth Israel Deaconnes MC

🇺🇸

Boston, Massachusetts, United States

The Ohio State University Medical Center

🇺🇸

Columbus, Ohio, United States

Fairview

🇺🇸

Cleveland, Ohio, United States

The University of North Carolina Hospitals

🇺🇸

Chapel Hill, North Carolina, United States

Wake Forest University Baptist Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

Danbury

🇺🇸

Danbury, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath